首页 > 最新文献

Seminars in Vascular Surgery最新文献

英文 中文
Team-based approach to arteriovenous access management 以团队为基础的动静脉通路管理方法
IF 2.4 3区 医学 Q1 PERIPHERAL VASCULAR DISEASE Pub Date : 2025-12-01 DOI: 10.1053/j.semvascsurg.2025.08.002
Christopher E. Holden-Wingate , Lucinda R. Holden-Wingate , Abraham Hussain , Navya R.K. Kotturu , Danielle Montano , Abena Appah-Sampong , Aurelie Tran , Brett J. Salomon , C. Keith Ozaki , Dirk M. Hentschel , Mohamad A. Hussain
More than 800,000 people live with end-stage kidney disease (ESKD) in the United States, and the incidence continues to rise. Further, the treatment landscape is evolving due to increasing prevalence of risk factors, such as diabetes and the aging United States population. More than ever, the creation and management of hemodialysis accesses require a multidisciplinary, team-based approach to provide care effectively. However, there is limited available research on the effects of multidisciplinary team (MDT)-based care in arteriovenous (AV) access outcomes and there remains no widely accepted standard regarding the composition and function of the required processes within an MDT. This manuscript provides an overview of the current literature on MDTs in AV access care, utilizing 5 specific examples where an MDT would be especially pertinent for optimizing patient care and outcomes. Our findings suggest a benefit from initiating an MDT model in AV access care and highlight potential improvements in catheter-free days and patient and provider satisfaction.
在美国,超过80万人患有终末期肾病(ESKD),而且发病率还在持续上升。此外,由于糖尿病和美国人口老龄化等危险因素的日益流行,治疗前景正在发生变化。血液透析通道的创建和管理比以往任何时候都更需要多学科、以团队为基础的方法来有效地提供护理。然而,基于多学科团队(MDT)的护理对动静脉(AV)通路结果的影响的现有研究有限,并且关于MDT中所需过程的组成和功能仍然没有广泛接受的标准。这篇文章概述了目前关于房颤通道护理中MDT的文献,并利用了5个具体的例子,其中MDT将特别适用于优化患者护理和结果。我们的研究结果表明,在房室通路护理中启动MDT模式是有益的,并强调了在无导管天数和患者和提供者满意度方面的潜在改进。
{"title":"Team-based approach to arteriovenous access management","authors":"Christopher E. Holden-Wingate ,&nbsp;Lucinda R. Holden-Wingate ,&nbsp;Abraham Hussain ,&nbsp;Navya R.K. Kotturu ,&nbsp;Danielle Montano ,&nbsp;Abena Appah-Sampong ,&nbsp;Aurelie Tran ,&nbsp;Brett J. Salomon ,&nbsp;C. Keith Ozaki ,&nbsp;Dirk M. Hentschel ,&nbsp;Mohamad A. Hussain","doi":"10.1053/j.semvascsurg.2025.08.002","DOIUrl":"10.1053/j.semvascsurg.2025.08.002","url":null,"abstract":"<div><div>More than 800,000 people live with end-stage kidney disease (ESKD) in the United States, and the incidence continues to rise. Further, the treatment landscape is evolving due to increasing prevalence of risk factors, such as diabetes and the aging United States population. More than ever, the creation and management of hemodialysis accesses require a multidisciplinary, team-based approach to provide care effectively. However, there is limited available research on the effects of multidisciplinary team (MDT)-based care in arteriovenous (AV) access outcomes and there remains no widely accepted standard regarding the composition and function of the required processes within an MDT. This manuscript provides an overview of the current literature on MDTs in AV access care, utilizing 5 specific examples where an MDT would be especially pertinent for optimizing patient care and outcomes. Our findings suggest a benefit from initiating an MDT model in AV access care and highlight potential improvements in catheter-free days and patient and provider satisfaction.</div></div>","PeriodicalId":51153,"journal":{"name":"Seminars in Vascular Surgery","volume":"38 4","pages":"Pages 404-411"},"PeriodicalIF":2.4,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145712386","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Management and Outcomes of Renal Artery Aneurysms in Older Adults 老年人肾动脉瘤的治疗和预后
IF 2.4 3区 医学 Q1 PERIPHERAL VASCULAR DISEASE Pub Date : 2025-09-01 DOI: 10.1053/j.semvascsurg.2025.07.003
Gloria Sanin, Elizabeth Wood, Heather Ots, Hope Werenski, Gabriela Velazquez
Renal artery aneurysms (RAAs) are rare but clinically significant vascular abnormalities. The management of RAA in older adults poses unique challenges related to their baseline comorbidities and age-related vascular changes. Traditionally, open surgery has been the gold standard for large or complex RAA. However, recent data and guidelines support a more conservative threshold for intervention and broader adoption of endovascular therapies, which offer lower perioperative morbidity, shorter hospital stays, and overall faster recovery. General indications for repair include symptomatic aneurysms, medically refractory hypertension, and lesions ≥3 cm. Medical management and surveillance are appropriate for asymptomatic patients with stable aneurysms < 3 cm, especially for those with limited life expectancy. Open surgical techniques include both in situ and ex vivo reconstructions with demonstrated long-term durability but are associated with higher perioperative risk. Endovascular techniques, including coil embolization and stent grafting, are increasingly being used in anatomically suitable patients with high success. Postoperative outcomes suggest comparable long-term results between open and endovascular approaches. However, endovascular repair is associated with fewer complications and is increasingly preferred in elderly or high-risk populations. An individualized approach is essential to optimize outcomes, balancing the risks of intervention with the natural history of the disease. This is a review of the epidemiology, diagnosis, management, and outcomes of RAAs in older adults.
肾动脉动脉瘤(RAAs)是一种罕见但临床上重要的血管异常。老年人RAA的管理面临着与基线合并症和年龄相关血管改变相关的独特挑战。传统上,开放手术一直是大型或复杂RAA的金标准。然而,最近的数据和指南支持更保守的干预阈值和更广泛地采用血管内治疗,其围手术期发病率更低,住院时间更短,总体上恢复更快。修复的一般适应症包括有症状的动脉瘤,医学上难治性高血压,病变≥3cm。对于无症状的3cm稳定型动脉瘤患者,特别是预期寿命有限的患者,应进行适当的医疗管理和监测。开放手术技术包括原位和体外重建,具有长期耐用性,但围手术期风险较高。血管内技术,包括线圈栓塞和支架移植,越来越多地被用于解剖学上合适的患者,并取得了很高的成功。术后结果表明,开放入路和血管内入路的长期结果相当。然而,血管内修复术并发症较少,在老年人或高危人群中越来越受欢迎。个性化的方法对于优化结果至关重要,可以平衡干预的风险和疾病的自然史。本文综述了老年人RAAs的流行病学、诊断、治疗和预后。
{"title":"Management and Outcomes of Renal Artery Aneurysms in Older Adults","authors":"Gloria Sanin,&nbsp;Elizabeth Wood,&nbsp;Heather Ots,&nbsp;Hope Werenski,&nbsp;Gabriela Velazquez","doi":"10.1053/j.semvascsurg.2025.07.003","DOIUrl":"10.1053/j.semvascsurg.2025.07.003","url":null,"abstract":"<div><div>Renal artery aneurysms (RAAs) are rare but clinically significant vascular abnormalities. The management of RAA in older adults poses unique challenges related to their baseline comorbidities and age-related vascular changes. Traditionally, open surgery has been the gold standard for large or complex RAA. However, recent data and guidelines support a more conservative threshold for intervention and broader adoption of endovascular therapies, which offer lower perioperative morbidity, shorter hospital stays, and overall faster recovery. General indications for repair include symptomatic aneurysms, medically refractory hypertension, and lesions ≥3 cm. Medical management and surveillance are appropriate for asymptomatic patients with stable aneurysms &lt; 3 cm, especially for those with limited life expectancy. Open surgical techniques include both in situ and ex vivo reconstructions with demonstrated long-term durability but are associated with higher perioperative risk. Endovascular techniques, including coil embolization and stent grafting, are increasingly being used in anatomically suitable patients with high success. Postoperative outcomes suggest comparable long-term results between open and endovascular approaches. However, endovascular repair is associated with fewer complications and is increasingly preferred in elderly or high-risk populations. An individualized approach is essential to optimize outcomes, balancing the risks of intervention with the natural history of the disease. This is a review of the epidemiology, diagnosis, management, and outcomes of RAAs in older adults.</div></div>","PeriodicalId":51153,"journal":{"name":"Seminars in Vascular Surgery","volume":"38 3","pages":"Pages 258-270"},"PeriodicalIF":2.4,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145007592","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Management of claudication in older adults and the role of exercise therapy 老年人跛行的管理和运动治疗的作用
IF 2.4 3区 医学 Q1 PERIPHERAL VASCULAR DISEASE Pub Date : 2025-09-01 DOI: 10.1053/j.semvascsurg.2025.07.005
Oliver O. Aalami , Matthew A. Corriere
Claudication from peripheral artery disease is a common mobility-limiting condition in older adults. Exercise therapy, whether delivered through supervised programs or structured home-based programs, plays a central role in claudication care for older adults, offering substantial functional gains with minimal risk, and should be the cornerstone of management alongside optimized medical therapy. This review examines contemporary management of claudication in the aging population, with emphasis on exercise therapy. Treatment modalities, including best medical therapy, supervised exercise therapy, home-based exercise programs, and invasive interventions (endovascular and open surgery) are critically evaluated. Pharmacotherapy (eg, cilostazol) can modestly improve walking distance, and aggressive risk factor control (eg, smoking cessation and statins) is imperative for all patients. Invasive revascularization is reserved for select individuals with lifestyle-limiting claudication unresponsive to conservative measures, given procedural risks and the potential for repeated interventions. Recent society guidelines (American College of Cardiology and the American Heart Association 2016 and European Society for Vascular Surgery 2024) and the Society for Vascular Surgery's 2025 focused update uniformly endorse exercise and medical therapy as initial management, restricting revascularization to severe claudication after conservative therapy trials and emphasizing individualized shared decision-making approaches. Claudication outcomes (ankle–brachial index changes, 6-minute walk improvements, and patient-reported outcomes) across treatments are reviewed alongside indications, contraindications, and benefits of each strategy.
外周动脉疾病引起的跛行是老年人常见的活动受限疾病。运动疗法,无论是通过有监督的项目还是有组织的家庭项目,在老年人的跛行护理中发挥着核心作用,以最小的风险提供大量的功能收益,应该成为优化药物治疗的管理基石。这篇综述探讨了老年人群跛行的当代管理,重点是运动疗法。治疗方式,包括最好的药物治疗,监督运动治疗,以家庭为基础的锻炼计划,和侵入性干预(血管内和开放手术)进行严格评估。药物治疗(如西洛他唑)可以适度改善步行距离,积极的危险因素控制(如戒烟和他汀类药物)对所有患者都是必要的。考虑到手术风险和重复干预的可能性,有创性血运重建术只适用于生活方式受限的跛行患者。最近的社会指南(美国心脏病学会和美国心脏协会2016年和欧洲血管外科学会2024年)和血管外科学会2025年的重点更新一致支持运动和药物治疗作为初始管理,限制在保守治疗试验后的严重跛行血供重建术,并强调个性化的共同决策方法。不同治疗的跛行结果(踝-肱指数改变、6分钟步行改善和患者报告的结果)以及每种策略的适应症、禁忌症和益处进行了回顾。
{"title":"Management of claudication in older adults and the role of exercise therapy","authors":"Oliver O. Aalami ,&nbsp;Matthew A. Corriere","doi":"10.1053/j.semvascsurg.2025.07.005","DOIUrl":"10.1053/j.semvascsurg.2025.07.005","url":null,"abstract":"<div><div>Claudication from peripheral artery disease is a common mobility-limiting condition in older adults. Exercise therapy, whether delivered through supervised programs or structured home-based programs, plays a central role in claudication care for older adults, offering substantial functional gains with minimal risk, and should be the cornerstone of management alongside optimized medical therapy. This review examines contemporary management of claudication in the aging population, with emphasis on exercise therapy. Treatment modalities, including best medical therapy, supervised exercise therapy, home-based exercise programs, and invasive interventions (endovascular and open surgery) are critically evaluated. Pharmacotherapy (eg, cilostazol) can modestly improve walking distance, and aggressive risk factor control (eg, smoking cessation and statins) is imperative for all patients. Invasive revascularization is reserved for select individuals with lifestyle-limiting claudication unresponsive to conservative measures, given procedural risks and the potential for repeated interventions. Recent society guidelines (American College of Cardiology and the American Heart Association 2016 and European Society for Vascular Surgery 2024) and the Society for Vascular Surgery's 2025 focused update uniformly endorse exercise and medical therapy as initial management, restricting revascularization to severe claudication after conservative therapy trials and emphasizing individualized shared decision-making approaches. Claudication outcomes (ankle–brachial index changes, 6-minute walk improvements, and patient-reported outcomes) across treatments are reviewed alongside indications, contraindications, and benefits of each strategy.</div></div>","PeriodicalId":51153,"journal":{"name":"Seminars in Vascular Surgery","volume":"38 3","pages":"Pages 271-280"},"PeriodicalIF":2.4,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145007524","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Management and outcomes of chronic mesenteric ischemia in older adults: A comprehensive review 老年人慢性肠系膜缺血的处理和结果:一项全面的综述
IF 2.4 3区 医学 Q1 PERIPHERAL VASCULAR DISEASE Pub Date : 2025-09-01 DOI: 10.1053/j.semvascsurg.2025.06.001
Yashashwini Sudina , Hind Anan , Joelle Daher , Rabih A. Chaer
Chronic mesenteric ischemia (CMI) is a rare, yet increasingly prevalent, condition, especially among older adults. Diagnosing CMI in older adults presents significant challenges. Along with the burden of comorbidities and the physiological changes associated with aging, timely intervention is often delayed, leading to poorer outcomes. Current diagnostic protocols and treatment guidelines do not address the unique challenges faced by this population. In this comprehensive review, the authors examined the existing literature on diagnostic strategies and management options for CMI in older adults. The importance of a thorough preoperative workup and early optimization to minimize perioperative stress, while considering nutritional and functional capabilities, is emphasized. Risk stratification models incorporating frailty and other geriatric-specific indices can inform therapeutic decisions and improve outcomes. Despite the increasing disease burden in this group, there are limited data on long-term outcomes, the impact of nutrition, and quality of life metrics after intervention. This emphasizes the necessity for more prospective studies to address these gaps and implement age-specific approaches for the evaluation and treatment of older adult patients with CMI.
慢性肠系膜缺血(CMI)是一种罕见但越来越普遍的疾病,尤其是在老年人中。老年CMI的诊断面临着重大挑战。随着合并症的负担和与衰老相关的生理变化,及时干预往往被推迟,导致预后较差。目前的诊断方案和治疗指南没有解决这一人群面临的独特挑战。在这篇全面的综述中,作者检查了现有的关于老年人CMI的诊断策略和管理选择的文献。强调全面的术前检查和早期优化的重要性,以尽量减少围手术期应激,同时考虑营养和功能能力。纳入虚弱和其他老年特异性指标的风险分层模型可以为治疗决策提供信息并改善结果。尽管这一群体的疾病负担不断增加,但有关干预后的长期结局、营养影响和生活质量指标的数据有限。这强调需要更多的前瞻性研究来解决这些差距,并实施针对年龄的方法来评估和治疗老年CMI患者。
{"title":"Management and outcomes of chronic mesenteric ischemia in older adults: A comprehensive review","authors":"Yashashwini Sudina ,&nbsp;Hind Anan ,&nbsp;Joelle Daher ,&nbsp;Rabih A. Chaer","doi":"10.1053/j.semvascsurg.2025.06.001","DOIUrl":"10.1053/j.semvascsurg.2025.06.001","url":null,"abstract":"<div><div>Chronic mesenteric ischemia (CMI) is a rare, yet increasingly prevalent, condition, especially among older adults. Diagnosing CMI in older adults presents significant challenges. Along with the burden of comorbidities and the physiological changes associated with aging, timely intervention is often delayed, leading to poorer outcomes. Current diagnostic protocols and treatment guidelines do not address the unique challenges faced by this population. In this comprehensive review, the authors examined the existing literature on diagnostic strategies and management options for CMI in older adults. The importance of a thorough preoperative workup and early optimization to minimize perioperative stress, while considering nutritional and functional capabilities, is emphasized. Risk stratification models incorporating frailty and other geriatric-specific indices can inform therapeutic decisions and improve outcomes. Despite the increasing disease burden in this group, there are limited data on long-term outcomes, the impact of nutrition, and quality of life metrics after intervention. This emphasizes the necessity for more prospective studies to address these gaps and implement age-specific approaches for the evaluation and treatment of older adult patients with CMI.</div></div>","PeriodicalId":51153,"journal":{"name":"Seminars in Vascular Surgery","volume":"38 3","pages":"Pages 250-257"},"PeriodicalIF":2.4,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145007591","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Navigating treatment decisions for CLTI in older adults: Primary amputation vs revascularization 引导老年人CLTI的治疗决策:原发性截肢与血运重建术
IF 2.4 3区 医学 Q1 PERIPHERAL VASCULAR DISEASE Pub Date : 2025-09-01 DOI: 10.1053/j.semvascsurg.2025.06.006
Shannon N. Radomski, Courtenay M. Holscher
As the world’s elderly population continues to grow, the proportion of people living with chronic medical conditions is also increasing. Cardiovascular diseases including hypertension, diabetes, and atherosclerosis are among the most common, and as a result peripheral artery disease (PAD) is increasingly prevalent in this population. It is estimated that 15% to 20% of the elderly population has been diagnosed with PAD, and consequentially there is also a large proportion who have progressed to chronic limb threatening ischemia (CLTI). The management of this end stage of PAD is complex regardless of age, as there is high variability in current practice patterns and a lack of consensus on endovascular or surgical bypass as the initial treatment modality. The treatment paradigm becomes even more complicated in the elderly population, and special considerations must be given to treatment including the decision to offer revascularization (surgical or endovascular) vs primary amputation. This article explores the risks and benefits of the 2 approaches in the context of mortality, quality of life, and cost in the elderly population. Although there is good evidence that revascularization confers benefits in mortality, quality of life, and cost, there are also data that indicate that this approach should only be offered to fully independent individuals as outcomes in those with a nonambulatory status preoperatively are poor. Overall, the authors advocate for a patient-centered, multidisciplinary approach to treating CLTI in this population that focuses first and foremost on patient goals.
随着世界老年人口的持续增长,慢性病患者的比例也在增加。包括高血压、糖尿病和动脉粥样硬化在内的心血管疾病是最常见的,因此外周动脉疾病(PAD)在这一人群中越来越普遍。据估计,老年人群中有15% - 20%被诊断为PAD,因此也有很大比例的人发展为慢性肢体威胁缺血(CLTI)。无论年龄大小,晚期PAD的治疗都很复杂,因为目前的实践模式存在很大的差异,并且对血管内或手术旁路治疗作为初始治疗方式缺乏共识。在老年人群中,治疗模式变得更加复杂,必须特别考虑治疗,包括决定提供血运重建术(手术或血管内)还是原发性截肢。本文探讨了这两种方法在老年人死亡率、生活质量和成本方面的风险和收益。虽然有充分的证据表明,血运重建术在死亡率、生活质量和成本方面都有好处,但也有数据表明,这种方法只应提供给完全独立的个体,因为术前不能走动的患者预后较差。总的来说,作者提倡以患者为中心,多学科的方法来治疗CLTI,首先关注患者的目标。
{"title":"Navigating treatment decisions for CLTI in older adults: Primary amputation vs revascularization","authors":"Shannon N. Radomski,&nbsp;Courtenay M. Holscher","doi":"10.1053/j.semvascsurg.2025.06.006","DOIUrl":"10.1053/j.semvascsurg.2025.06.006","url":null,"abstract":"<div><div>As the world’s elderly population continues to grow, the proportion of people living with chronic medical conditions is also increasing. Cardiovascular diseases including hypertension, diabetes, and atherosclerosis are among the most common, and as a result peripheral artery disease (PAD) is increasingly prevalent in this population. It is estimated that 15% to 20% of the elderly population has been diagnosed with PAD, and consequentially there is also a large proportion who have progressed to chronic limb threatening ischemia (CLTI). The management of this end stage of PAD is complex regardless of age, as there is high variability in current practice patterns and a lack of consensus on endovascular or surgical bypass as the initial treatment modality. The treatment paradigm becomes even more complicated in the elderly population, and special considerations must be given to treatment including the decision to offer revascularization (surgical or endovascular) vs primary amputation. This article explores the risks and benefits of the 2 approaches in the context of mortality, quality of life, and cost in the elderly population. Although there is good evidence that revascularization confers benefits in mortality, quality of life, and cost, there are also data that indicate that this approach should only be offered to fully independent individuals as outcomes in those with a nonambulatory status preoperatively are poor. Overall, the authors advocate for a patient-centered, multidisciplinary approach to treating CLTI in this population that focuses first and foremost on patient goals.</div></div>","PeriodicalId":51153,"journal":{"name":"Seminars in Vascular Surgery","volume":"38 3","pages":"Pages 291-300"},"PeriodicalIF":2.4,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145007517","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hemodialysis access planning and outcomes in older adults 老年人血液透析获取计划和结果
IF 2.4 3区 医学 Q1 PERIPHERAL VASCULAR DISEASE Pub Date : 2025-09-01 DOI: 10.1053/j.semvascsurg.2025.06.008
Lucinda R. Holden-Wingate , Christopher E. Holden-Wingate , Abena Appah-Sampong , Melissa Cruz , C. Keith Ozaki , Dirk M. Hentschel , Mohamad A. Hussain
The rate of end-stage kidney disease (ESKD) is steadily rising in the United States, and older adults (ie, 65 years and older) represent the fastest-growing segment in need of hemodialysis. This demographic shift presents unique challenges due to age-related comorbidities, frailty, and increased procedural risks. Despite these challenges, there is limited guidance for risk stratification and management of renal replacement therapy in older patients with ESKD. The authors provide a review of current literature and tools to characterize high-risk older patients with ESKD, focusing on the following three key considerations when planning for permanent hemodialysis access placement: vascular anatomy, frailty, and ESKD Life-Plan considerations. Within this population of older patients, consideration of areas of focus for the history and physical examination, preoperative vascular imaging studies, hemodialysis access type, timing of access placement, type of anesthesia used, and multidisciplinary teams are discussed. Our findings suggest that applying a systematic approach to care that incorporates these key considerations may present a route for improving outcomes in this vulnerable population; however, further research is needed.
在美国,终末期肾病(ESKD)的发病率正在稳步上升,老年人(即65岁及以上)是血液透析需求增长最快的人群。由于与年龄相关的合并症、虚弱和增加的手术风险,这种人口结构的转变带来了独特的挑战。尽管存在这些挑战,对于老年ESKD患者肾替代治疗的风险分层和管理的指导仍然有限。作者回顾了目前的文献和工具,以确定高风险老年ESKD患者的特征,重点是在计划永久性血液透析通道放置时的以下三个关键考虑因素:血管解剖、脆弱性和ESKD生命计划考虑因素。在老年患者中,我们讨论了病史和体格检查的重点领域、术前血管成像研究、血液透析通路类型、通路放置时间、使用的麻醉类型和多学科团队。我们的研究结果表明,采用一种系统的护理方法,结合这些关键因素,可能会为改善这一弱势群体的结局提供一条途径;然而,还需要进一步的研究。
{"title":"Hemodialysis access planning and outcomes in older adults","authors":"Lucinda R. Holden-Wingate ,&nbsp;Christopher E. Holden-Wingate ,&nbsp;Abena Appah-Sampong ,&nbsp;Melissa Cruz ,&nbsp;C. Keith Ozaki ,&nbsp;Dirk M. Hentschel ,&nbsp;Mohamad A. Hussain","doi":"10.1053/j.semvascsurg.2025.06.008","DOIUrl":"10.1053/j.semvascsurg.2025.06.008","url":null,"abstract":"<div><div>The rate of end-stage kidney disease (ESKD) is steadily rising in the United States, and older adults (ie, 65 years and older) represent the fastest-growing segment in need of hemodialysis. This demographic shift presents unique challenges due to age-related comorbidities, frailty, and increased procedural risks. Despite these challenges, there is limited guidance for risk stratification and management of renal replacement therapy in older patients with ESKD. The authors provide a review of current literature and tools to characterize high-risk older patients with ESKD, focusing on the following three key considerations when planning for permanent hemodialysis access placement: vascular anatomy, frailty, and ESKD Life-Plan considerations. Within this population of older patients, consideration of areas of focus for the history and physical examination, preoperative vascular imaging studies, hemodialysis access type, timing of access placement, type of anesthesia used, and multidisciplinary teams are discussed. Our findings suggest that applying a systematic approach to care that incorporates these key considerations may present a route for improving outcomes in this vulnerable population; however, further research is needed.</div></div>","PeriodicalId":51153,"journal":{"name":"Seminars in Vascular Surgery","volume":"38 3","pages":"Pages 314-322"},"PeriodicalIF":2.4,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145007525","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ethical considerations and the role of shared decision making in the vascular care of older adults 伦理考虑和共同决策在老年人血管护理中的作用
IF 2.4 3区 医学 Q1 PERIPHERAL VASCULAR DISEASE Pub Date : 2025-09-01 DOI: 10.1053/j.semvascsurg.2025.06.002
Carly G. Sobol, Corinne Praska, Margaret L. Schwarze
Vascular surgeons are often responsible for navigating treatment decisions when caring for older adults. Care for these patients is informed by the surgeon’s assessment of the patient’s decision-making capacity, use of advance care planning, and understanding of futility. Having difficult conversations with patients and their families is supported by strategies that promote empathic communication and shared decision making with older adults with serious illness due to, and associated with, vascular disease. These strategies include avoiding the cognitive trap, using heads-up and headline statements, best case and worst case to manage uncertainty, and better conversations to provide informed consent.
在照顾老年人时,血管外科医生通常负责指导治疗决策。对这些患者的护理是由外科医生对患者决策能力的评估、预先护理计划的使用和对无效的理解来告知的。与患者及其家属进行困难对话的策略是促进与患有由血管疾病引起或与血管疾病相关的严重疾病的老年人进行共情沟通和共同决策。这些策略包括避免认知陷阱,使用警告和标题声明,最好的情况和最坏的情况来管理不确定性,以及更好的对话来提供知情同意。
{"title":"Ethical considerations and the role of shared decision making in the vascular care of older adults","authors":"Carly G. Sobol,&nbsp;Corinne Praska,&nbsp;Margaret L. Schwarze","doi":"10.1053/j.semvascsurg.2025.06.002","DOIUrl":"10.1053/j.semvascsurg.2025.06.002","url":null,"abstract":"<div><div><span><span>Vascular surgeons are often responsible for navigating treatment decisions when caring for older adults. Care for these patients is informed by the surgeon’s assessment of the patient’s decision-making capacity, use of </span>advance care planning, and understanding of futility. Having difficult conversations with patients and their families is supported by strategies that promote empathic communication and </span>shared decision making<span> with older adults with serious illness due to, and associated with, vascular disease. These strategies include avoiding the cognitive trap, using heads-up and headline statements, best case and worst case to manage uncertainty, and better conversations to provide informed consent.</span></div></div>","PeriodicalId":51153,"journal":{"name":"Seminars in Vascular Surgery","volume":"38 3","pages":"Pages 332-338"},"PeriodicalIF":2.4,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145007527","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Open revascularization for infrainguinal peripheral arterial disease in elderly patients: A scoping review 老年患者腹股沟下外周动脉疾病的开放血运重建术:范围综述
IF 2.4 3区 医学 Q1 PERIPHERAL VASCULAR DISEASE Pub Date : 2025-09-01 DOI: 10.1053/j.semvascsurg.2025.07.004
Grace Yu , Yana Etkin , Jeffrey Silpe
Peripheral arterial disease (PAD) is a prevalent and debilitating condition in elderly patients, often leading to critical limb threatening ischemia (CLTI) and major amputations. While endovascular interventions are usually preferred for their lower perioperative risk, open surgical revascularization should also be considered due to its durability and superior patency in complex disease patterns. Age alone does not determine suitability for surgery; rather, candidacy hinges on frailty, functional status, comorbidities, and anatomical considerations. Contemporary global guidelines endorse a patient-centered approach that integrates these multidimensional factors. This scoping review will evaluate the outcomes of open infrainguinal revascularization in patients over 70, compared to endovascular approaches, and discuss how these findings align with contemporary guidelines and clinical decision-making paradigms. A scoping review was performed using one independent reviewer who screened PubMed to identify peer-reviewed observational studies and randomized controlled trials (2004-2024) involving patients aged >70 undergoing open infrainguinal revascularization. Keywords included “infrainguinal PAD,” “open revascularization,” and “elderly.” Key data extracted included perioperative morbidity, mortality, graft patency, limb salvage, and comparative effectiveness against endovascular strategies. A total of 1,574 articles were identified through reference search. We then screened these articles and assessed 265 full-text articles for eligibility. After exclusion, 19 full-text articles were selected for final inclusion. Nineteen eligible studies were included. Open revascularization in the elderly demonstrated 30-day mortality rates of 2% to 5% and 80% to 90% limb salvage rates in patients. Compared to endovascular techniques, open bypass yielded lower reintervention rates and superior long-term patency, especially when an autologous vein was used. Endovascular procedures were favored in high-risk or frail patients for their favorable perioperative profile. Frailty, functional independence, and conduit availability emerged as key determinants of surgical success. Open infrainguinal revascularization remains a viable and often preferable option for select elderly PAD patients. Decision-making should prioritize biological age, anatomical suitability, and patient preferences over chronological age. A multidisciplinary, guideline-driven approach can optimize outcomes, minimize risk, and preserve limb function and quality of life in this growing population.
外周动脉疾病(PAD)是老年患者中一种常见的衰弱性疾病,常导致严重肢体威胁缺血(CLTI)和大面积截肢。虽然血管内介入术的围手术期风险较低,但由于其在复杂疾病模式下的耐久性和良好的通畅性,也应考虑开放手术血运重建术。年龄本身不能决定手术的适宜性;相反,候选资格取决于虚弱,功能状态,合并症和解剖学考虑。当代全球指南支持以患者为中心的方法,将这些多维因素整合在一起。本综述将评估70岁以上患者的开放式腹股沟下血运重建术与血管内入路的结果,并讨论这些结果如何与当代指南和临床决策范例相一致。一名独立审稿人筛选PubMed,以确定同行评议的观察性研究和随机对照试验(2004-2024),涉及70岁接受开放式腹股沟下血管重建术的患者。关键词包括“腹股沟下PAD”、“开放式血供重建术”和“老年人”。提取的关键数据包括围手术期发病率、死亡率、移植物通畅、肢体保留以及相对于血管内策略的有效性。通过参考文献检索,共检索到1574篇文献。然后,我们筛选了这些文章,并评估了265篇全文文章的合格性。排除后,19篇全文文章入选。纳入了19项符合条件的研究。老年人开放血运重建术30天死亡率为2% ~ 5%,肢体保留率为80% ~ 90%。与血管内技术相比,开放旁路手术的再介入率较低,长期通畅性较好,特别是当使用自体静脉时。血管内手术因其良好的围手术期特点而被高危或体弱患者所青睐。虚弱、功能独立和导管可用性成为手术成功的关键决定因素。开放式腹股沟下血运重建术仍然是一种可行的选择,通常是老年PAD患者的首选。决策时应优先考虑生理年龄、解剖适应性和患者偏好,而不是实际年龄。多学科、指南驱动的方法可以优化结果,降低风险,并在这一不断增长的人群中保持肢体功能和生活质量。
{"title":"Open revascularization for infrainguinal peripheral arterial disease in elderly patients: A scoping review","authors":"Grace Yu ,&nbsp;Yana Etkin ,&nbsp;Jeffrey Silpe","doi":"10.1053/j.semvascsurg.2025.07.004","DOIUrl":"10.1053/j.semvascsurg.2025.07.004","url":null,"abstract":"<div><div>Peripheral arterial disease (PAD) is a prevalent and debilitating condition in elderly patients, often leading to critical limb threatening ischemia (CLTI) and major amputations. While endovascular interventions are usually preferred for their lower perioperative risk, open surgical revascularization should also be considered due to its durability and superior patency in complex disease patterns. Age alone does not determine suitability for surgery; rather, candidacy hinges on frailty, functional status, comorbidities, and anatomical considerations. Contemporary global guidelines endorse a patient-centered approach that integrates these multidimensional factors. This scoping review will evaluate the outcomes of open infrainguinal revascularization in patients over 70, compared to endovascular approaches, and discuss how these findings align with contemporary guidelines and clinical decision-making paradigms. A scoping review was performed using one independent reviewer who screened PubMed to identify peer-reviewed observational studies and randomized controlled trials (2004-2024) involving patients aged &gt;70 undergoing open infrainguinal revascularization. Keywords included “infrainguinal PAD,” “open revascularization,” and “elderly.” Key data extracted included perioperative morbidity, mortality, graft patency, limb salvage, and comparative effectiveness against endovascular strategies. A total of 1,574 articles were identified through reference search. We then screened these articles and assessed 265 full-text articles for eligibility. After exclusion, 19 full-text articles were selected for final inclusion. Nineteen eligible studies were included. Open revascularization in the elderly demonstrated 30-day mortality rates of 2% to 5% and 80% to 90% limb salvage rates in patients. Compared to endovascular techniques, open bypass yielded lower reintervention rates and superior long-term patency, especially when an autologous vein was used. Endovascular procedures were favored in high-risk or frail patients for their favorable perioperative profile. Frailty, functional independence, and conduit availability emerged as key determinants of surgical success. Open infrainguinal revascularization remains a viable and often preferable option for select elderly PAD patients. Decision-making should prioritize biological age, anatomical suitability, and patient preferences over chronological age. A multidisciplinary, guideline-driven approach can optimize outcomes, minimize risk, and preserve limb function and quality of life in this growing population.</div></div>","PeriodicalId":51153,"journal":{"name":"Seminars in Vascular Surgery","volume":"38 3","pages":"Pages 301-313"},"PeriodicalIF":2.4,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145007523","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Management and outcomes of asymptomatic carotid stenosis in octogenarians and nonagenarians 80岁和90岁老人无症状颈动脉狭窄的处理和结局
IF 2.4 3区 医学 Q1 PERIPHERAL VASCULAR DISEASE Pub Date : 2025-09-01 DOI: 10.1053/j.semvascsurg.2025.07.001
Karen Velez, Julia Caldropoli, Sonia Talathi
As medicine evolves and life expectancy increases, octogenarians and nonagenarians represent growing populations that are at increased risk of ischemic stroke from asymptomatic carotid stenosis (ACS). Despite the significant disability and mortality that results from stroke in older adults, there are few data on the management of ACS in this population to inform clinical practice guidelines. The authors sought to assess the current body of literature on the management and outcomes of ACS in older adults. Prior landmark randomized controlled trials comparing carotid endarterectomy with best medical therapy alone have been questioned, as modern best medical therapy strategies have significantly evolved since their conception. These studies either do not include octogenarians and nonagenarians or involve a limited sample size, making it challenging to apply these findings to older adult population. Two particular areas of interest in our review are the potential benefits of carotid revascularization and risk stratification. Retrospective studies suggest that carotid endarterectomy may improve cognitive functioning in older adults. Frailty is shown to be associated with worse postoperative outcomes of carotid revascularization in the general population, although few data exist on the impact of frailty on outcomes in octogenarians and nonagenarians. Overall, there is a limited body of literature informing the clinical management of ACS in octogenarians and nonagenarians, and future randomized controlled trials are needed to compare outcomes of carotid revascularization with best medical therapy alone in this population.
随着医学的发展和预期寿命的增加,80多岁和90多岁的人是无症状颈动脉狭窄(ACS)缺血性中风风险增加的人群。尽管老年人中风导致显著的残疾和死亡率,但在这一人群中,ACS的管理数据很少,无法为临床实践指南提供信息。作者试图评估目前关于老年人ACS的管理和结果的文献。先前比较颈动脉内膜切除术与单独最佳药物治疗的具有里程碑意义的随机对照试验受到质疑,因为现代最佳药物治疗策略自其构想以来已显著发展。这些研究要么没有包括80多岁和90多岁的老人,要么涉及的样本量有限,这使得将这些发现应用于老年人群体具有挑战性。在我们的综述中,两个特别感兴趣的领域是颈动脉血运重建术和风险分层的潜在益处。回顾性研究表明,颈动脉内膜切除术可以改善老年人的认知功能。在一般人群中,虚弱与颈动脉血管重建术术后较差的预后有关,尽管很少有数据表明虚弱对80岁和90岁老人预后的影响。总的来说,关于80多岁和90多岁老人ACS的临床管理的文献有限,需要未来的随机对照试验来比较这一人群中颈动脉血运重建术与最佳药物治疗的结果。
{"title":"Management and outcomes of asymptomatic carotid stenosis in octogenarians and nonagenarians","authors":"Karen Velez,&nbsp;Julia Caldropoli,&nbsp;Sonia Talathi","doi":"10.1053/j.semvascsurg.2025.07.001","DOIUrl":"10.1053/j.semvascsurg.2025.07.001","url":null,"abstract":"<div><div>As medicine evolves and life expectancy increases, octogenarians and nonagenarians represent growing populations that are at increased risk of ischemic stroke from asymptomatic carotid stenosis (ACS). Despite the significant disability and mortality that results from stroke in older adults, there are few data on the management of ACS in this population to inform clinical practice guidelines. The authors sought to assess the current body of literature on the management and outcomes of ACS in older adults. Prior landmark randomized controlled trials comparing carotid endarterectomy with best medical therapy alone have been questioned, as modern best medical therapy strategies have significantly evolved since their conception. These studies either do not include octogenarians and nonagenarians or involve a limited sample size, making it challenging to apply these findings to older adult population. Two particular areas of interest in our review are the potential benefits of carotid revascularization and risk stratification. Retrospective studies suggest that carotid endarterectomy may improve cognitive functioning in older adults. Frailty is shown to be associated with worse postoperative outcomes of carotid revascularization in the general population, although few data exist on the impact of frailty on outcomes in octogenarians and nonagenarians. Overall, there is a limited body of literature informing the clinical management of ACS in octogenarians and nonagenarians, and future randomized controlled trials are needed to compare outcomes of carotid revascularization with best medical therapy alone in this population.</div></div>","PeriodicalId":51153,"journal":{"name":"Seminars in Vascular Surgery","volume":"38 3","pages":"Pages 219-224"},"PeriodicalIF":2.4,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145007583","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Outcomes of ruptured abdominal aortic aneurysms in older adults and who should be offered surgery 老年人腹主动脉瘤破裂的结局和谁应该提供手术
IF 2.4 3区 医学 Q1 PERIPHERAL VASCULAR DISEASE Pub Date : 2025-09-01 DOI: 10.1053/j.semvascsurg.2025.07.007
Colby Meinke, Kristina A. Giles
As life expectancy increases, the prevalence of ruptured abdominal aortic aneurysms (rAAA) poses a significant challenge for our healthcare system. Aging induces biochemical changes, including degradation of the extracellular matrix and loss of vascular smooth muscle cells, which increase the propensity for the development of aneurysms and subsequent rupture due to compromised integrity of the aortic wall. The mortality rate for elderly patients presenting with rAAA is high, ranging from 80 to 90%. Both open and endovascular repair come with substantial risk for elderly patients. While EVAR has been shown to have lower perioperative mortality in this population, elderly patients face significant post-operative recovery challenges related to age and frailty. In determining who should be offered surgery for rAAA, patient selection is crucial. Frailty and existing comorbidities should be factored into whether or not patients are offered surgery. A tailored approach that is individualized to patient specific goals and accounts for pre-existing comorbidities and functional status is essential to improving outcomes for elderly patients presenting with rAAA.
随着预期寿命的增加,腹主动脉瘤破裂(rAAA)的患病率对我们的医疗保健系统提出了重大挑战。衰老引起生物化学变化,包括细胞外基质的降解和血管平滑肌细胞的丧失,这增加了动脉瘤发展的倾向,并由于主动脉壁完整性受损而导致随后的破裂。老年rAAA患者的死亡率很高,从80%到90%不等。对于老年患者,开放和血管内修复都有很大的风险。虽然EVAR已被证明在这一人群中具有较低的围手术期死亡率,但老年患者面临着与年龄和虚弱相关的重大术后恢复挑战。在决定谁应该接受rAAA手术时,患者的选择是至关重要的。患者是否接受手术应考虑到虚弱和现有的合并症。针对患者的具体目标,考虑已有的合并症和功能状态,量身定制的方法对于改善老年rAAA患者的预后至关重要。
{"title":"Outcomes of ruptured abdominal aortic aneurysms in older adults and who should be offered surgery","authors":"Colby Meinke,&nbsp;Kristina A. Giles","doi":"10.1053/j.semvascsurg.2025.07.007","DOIUrl":"10.1053/j.semvascsurg.2025.07.007","url":null,"abstract":"<div><div>As life expectancy increases, the prevalence of ruptured abdominal aortic aneurysms (rAAA) poses a significant challenge for our healthcare system. Aging induces biochemical changes, including degradation of the extracellular matrix and loss of vascular smooth muscle cells, which increase the propensity for the development of aneurysms and subsequent rupture due to compromised integrity of the aortic wall. The mortality rate for elderly patients presenting with rAAA is high, ranging from 80 to 90%. Both open and endovascular repair come with substantial risk for elderly patients. While EVAR has been shown to have lower perioperative mortality in this population, elderly patients face significant post-operative recovery challenges related to age and frailty. In determining who should be offered surgery for rAAA, patient selection is crucial. Frailty and existing comorbidities should be factored into whether or not patients are offered surgery. A tailored approach that is individualized to patient specific goals and accounts for pre-existing comorbidities and functional status is essential to improving outcomes for elderly patients presenting with rAAA.</div></div>","PeriodicalId":51153,"journal":{"name":"Seminars in Vascular Surgery","volume":"38 3","pages":"Pages 243-249"},"PeriodicalIF":2.4,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145007586","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Seminars in Vascular Surgery
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1